SENTRY

Malaysia’s FIRST Healthcare & Wellness centric marketplace. Becoming a one stop solution for all healthcare needs with the largest healthcare product selection & services. We help one look after their own health effortlessly as well as take care of loved ones wherever they may reside in Malaysia.

Campaign Closed RM 750,000 raised

125% of target	0 days left
Investors	5
Min Target	RM 600,000
Max Target	RM 2,000,000

Introduction

Sentry is an online store provider of medicines and healthcare products. It provides an online platform that offers prescription, over-the-counter drugs and healthcare and wellness products. It allows users to buy various healthcare products such as skincare, family care, baby care and many more. Apart from being an online store, Sentry also provide verified localized health articles from health experts and allow users to book online doctor consultation and lab tests too.

What We Do

The Challenge

The healthcare industry has not changed much since decades ago. For years, access to quality healthcare has been a challenge for most of us and with the demands on our lives now, it is all the more important that we get comprehensive and timely healthcare from one place.

Our Solution

Meeting the inadequacies in the healthcare delivery system through technological interventions. The healthcare marketplace startup aims at providing a platform which would enable a consumer to gain access to healthcare services at all levels, starting from having all their clinic visits and prescriptions recorded and stored to buy medicines online and getting them delivered to their doorstep to e-consultation with doctors and scheduling diagnostic tests, thereby making it a one-stop platform for healthcare needs.

Why Are We Different

Our Revenue Model

Subscription
- Freemium vendor to Premium vendor
- Marketplace Profit Sharing
- Supplement and Medications
Digital Ads
- Virtual Space / Virtual Real Estate (VRE)
- Programmatic Ad Serving

Our Market Opportunity

The global pharmaceuticals market was worth RM 4.08 trillion (USD $934.8 billion) in 2017, and will reach RM 5.107 trillion (USD $1.17 trillion) in 2021, growing at 5.8%. Domestically, the Malaysian pharmaceutical market is forecasted to grow from RM 10.039 billion (USD $2.3 billion) in 2015 to RM 15.714 billion (USD $3.6 billion) by 2020, representing a compound annual growth rate (CAGR) of 9.5%.

Source: The Business Research (2018), GlobalData (2016), CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia.

Our Strategy

Indicative Usage of Funds

The Team

Mak Kinn Lian

Chief Executive Officer

Michelle Koo

Chief Operating Officer

Term Sheet

Issuer: Sentry Network Sdn Bhd, a private company limited by shares incorporated in Malaysia , a private limited company incorporated in Malaysia

Type of Equity: Ordinary Shares (the "Shares")

Fund Raising Period: 90 days

Pre Money Valuation: RM21,000,000

Minimum Fundraising Target: RM 600,000

Maximum Fundraising Target: RM 2,000,000

Price per Share: RM 210.00

Minimum Equity Offered: 2.78%

Maximum Equity Offered: 8.70%

Minimum Shares Offered: 2858

Maximum Shares Offered: 9524

Minimum Investment Amount: RM 2,100

Rewards

Impact on Shareholding Structure Upon Completion of the Offering

Investor Eligibility: Retail, Angel, Sophisticated, and/or Institutional Investors, subject to the applicable investment limits prescribed under the Securities Commission’s Guidelines on Recognised Markets.

Pre Emptive Rights: Holders of the Shares are deemed to have agreed to waive their pre-emptive rights, if any, under section 85 of the Companies Act 2016.

Type of Shares

Information

Closing Period: 14 working days after the end of the Fundraising Period.

Use of Proceeds: 41.7% for research and development, 25% for marketing, 16.7% for sales, 10% for headquarter operations, 6.6% for support

Subscription Procedure: An Investment Agreement for the subscription of the Shares (subject to review if required or necessary).

Disclaimer

The information, calculations and remarks expressed on this term sheet or on any other part of the platform are based on information provided, disclosed and presented by the Issuer, Sentry Network Sdn Bhd to Ata Plus Sdn Bhd, either in part or in whole. Ata Plus disclaims responsibility for the accuracy, completeness and/or validity of these information, and hence will not be held liable for any inaccurate, inappropriate or incomplete information presented on this term sheet or on any other part of the platform subject to the following :

The financial information listed on the Deal page is provided by the Issuer; which includes the financial forecasts and projections, the capitalisation table, the term sheet, and management accounts.

The financial forecasts and projections have been prepared by the Issuer based on assumptions that have not been reviewed and certified by an independent certified accountant for its reasonableness.

The Issuer agrees that; all information concerning the product, business and the assets of the Issuer that have been furnished to Ata Plus Sdn Bhd for the purpose of the equity crowdfunding campaign is true, complete, and accurate in all material respects and is not misleading or deceptive whether by inclusion or omission.

Should the Investor require more information, they can do so by contacting Sentry Network Sdn Bhd directly by clicking on the ‘CONTACT’ button available on the Deal Page.

Disclosure: This issuer is referred by a 3rd party which is . Ata Plus is not associated or related to the issuer and the referral party.

Disclaimer by Securities Commission

(i) No shares will be alotted or issued based on this document after six months from the closing of the offer period

(ii) This issue, offer or invitation for the offering is a proposal not requiring authorisation of the Securities Commission under section 212(8) of the CMSA 2007

(iii) This document has not been reviewed by the Securities Commission Malaysia. The Securities Commission does not recommend nor assumes responsibility for any information including any statement, opinion or report disclosed in relation to this fund raising exercise and makes no representation as to its accuracy or completeness. The Securities Commission expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the information disclosed.

Issuer	Sentry Network Sdn Bhd, a private company limited by shares incorporated in Malaysia
Type of Equity	Ordinary Shares (the "Shares")
Fund Raising Period	90 days
Pre Money Valuation	RM21,000,000
Minimum Fundraising Target	RM 600,000
Maximum Fundraising Target	RM 2,000,000
Price per Share	RM 210.00
Minimum Equity Offered	2.78%
Maximum Equity Offered	8.70%
Minimum Shares Offered	2858
Maximum Shares Offered	9524
Minimum Investment Amount	RM 2,100
Rewards
Investor Eligibility	Retail, Angel, Sophisticated, and/or Institutional Investors, subject to the applicable investment limits prescribed under the Securities Commission’s Guidelines on Recognised Markets.
Pre Emptive Rights	Holders of the Shares are deemed to have agreed to waive their pre-emptive rights, if any, under section 85 of the Companies Act 2016.
Closing Period	14 working days after the end of the Fundraising Period.
Use of Proceeds	41.7% for research and development, 25% for marketing, 16.7% for sales, 10% for headquarter operations, 6.6% for support
Subscription Procedure	An Investment Agreement for the subscription of the Shares (subject to review if required or necessary).
Disclaimer	The information, calculations and remarks expressed on this term sheet or on any other part of the platform are based on information provided, disclosed and presented by the Issuer, Sentry Network Sdn Bhd to Ata Plus Sdn Bhd, either in part or in whole. Ata Plus disclaims responsibility for the accuracy, completeness and/or validity of these information, and hence will not be held liable for any inaccurate, inappropriate or incomplete information presented on this term sheet or on any other part of the platform subject to the following : The financial information listed on the Deal page is provided by the Issuer; which includes the financial forecasts and projections, the capitalisation table, the term sheet, and management accounts. The financial forecasts and projections have been prepared by the Issuer based on assumptions that have not been reviewed and certified by an independent certified accountant for its reasonableness. The Issuer agrees that; all information concerning the product, business and the assets of the Issuer that have been furnished to Ata Plus Sdn Bhd for the purpose of the equity crowdfunding campaign is true, complete, and accurate in all material respects and is not misleading or deceptive whether by inclusion or omission. Should the Investor require more information, they can do so by contacting Sentry Network Sdn Bhd directly by clicking on the ‘CONTACT’ button available on the Deal Page.
Disclaimer by Securities Commission	(i) No shares will be alotted or issued based on this document after six months from the closing of the offer period (ii) This issue, offer or invitation for the offering is a proposal not requiring authorisation of the Securities Commission under section 212(8) of the CMSA 2007 (iii) This document has not been reviewed by the Securities Commission Malaysia. The Securities Commission does not recommend nor assumes responsibility for any information including any statement, opinion or report disclosed in relation to this fund raising exercise and makes no representation as to its accuracy or completeness. The Securities Commission expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the information disclosed.

Risk Disclaimer

Investing in equity crowdfunding involves certain risks that include uncertainty of returns, lack of liquidity, dilution, material events and lack of control. Investments should be done as part of a diversiﬁed portfolio. ATA PLUS offers investment opportunities to investors who understands these risks in making their own investment decisions.

PLEASE READ THE FULL RISK WARNING BEFORE DECIDING TO INVEST.

This page is approved as a ﬁnancial promotion by ATA PLUS Sdn. Bhd., which is authorized and regulated by the Security Commission of Malaysia. Deals that are up for investment are only offered to members of ata-plus.com on the basis of information provided by the companies concerned. ATA PLUS takes no responsibility for this information or for any recommendations or opinions made by the companies. For further information on this, please read our Term of Use.